FIELD: medicine, neurology. SUBSTANCE: the present innovation deals with treating patients with demyelinizing diseases, multiple sclerosis, in particular. It includes introduction of proteolytic inhibitor and water-soluble antioxidant into different surface inguinal lymph nodes at single doses being by an order lower against average therapeutic ones at the rate of 0.4 ml/min daily for 20 d. EFFECT: improved results of therapy. 6 cl, 2 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING DIABETIC ANGIOPATHIES OF LOWER EXTREMITIES | 1999 |
|
RU2169008C2 |
PEPTIDE FROM THE COMPOSITION OF THE IMMUNOGLOBULIN HUMAN HEAVY CHAIN, SUITABLE FOR TREATMENT OF MULTIPLE SCLEROSIS | 2016 |
|
RU2646817C1 |
METHOD FOR PRODUCTION OF POLYCLONAL T-CELL VACCINE USEFUL IN TREATMENT OF IMMUNOLOGICAL DISORDERS | 2004 |
|
RU2277422C2 |
COMPOSITIONS FOR TREATMENT OF DISSEMINATED SCLEROSIS | 2008 |
|
RU2492234C2 |
METHOD FOR TREATING EXACERBATIONS IN CASE OF MULTIPLE SCLEROSIS | 2003 |
|
RU2257915C2 |
METHOD OF TREATING MULTIPLE SCLEROSIS IN CHILDREN | 2015 |
|
RU2596792C1 |
LIPOSOMES CONTAINING OLIGOPEPTIDES - FRAGMENTS OF MYELIN BASIC PROTEIN, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING MULTIPLE SCLEROSIS | 2009 |
|
RU2448685C2 |
ACTH-LIKE PEPTIDE WITH IMMUNOSUPRESSOR FUNCTION | 2017 |
|
RU2681317C1 |
THERAPEUTIC AGENT FOR TREATING PATHOLOGICAL SYNDROME AND METHOD OF TREATING MULTIPLE SCLEROSIS | 2011 |
|
RU2519196C2 |
METHOD FOR DIAGNOSTICS OF TREND IN MULTIPLE SCLEROSIS COURSE | 1988 |
|
RU2034299C1 |
Authors
Dates
2003-07-20—Published
2001-02-20—Filed